Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Baxter International Inc. has acquired AesRx, LLC, a private US biopharmaceutical company focused on orphan drug targets, including the development and commercialization of Aes-103, an investigational prophylactic treatment for sickle-cell...

Baxter International Inc. reports that upon completion of the tax-free distribution of the company's biopharmaceuticals business, Robert J. Hombach, currently chief financial officer for Baxter International Inc., will be appointed chief financial...

Bausch + Lomb is voluntarily recalling 849,044 tubes of an ophthalmic ointment due to crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye. The affected product is...

AbbVie has revised its proposal to acquire Shire PLC to Â£22.44 ($38.44) in cash and 0.8568 ordinary shares of New AbbVie for each Shire share or approximately $51 billion. This fourth proposal represents an indicative value of £51.15...

Actavis plc has filed an abbreviated new drug application (ANDA) with the US Food and Drug Administration (FDA) seeking approval to market dalfampridine extended-release tablets, 10 mg.  Actavis' ANDA product is a generic version of Acorda...

Cipla Limited, a global healthcare company headquartered in Mumbai, India, today announced its intention to make investments of up to £100 million ($171 million) in its UK subsidiary over the next few years The investment will fund the...

Mylan Inc. has launched telmisartan tablets USP, 20 mg, 40 mg and 80 mg, the generic version of Boehringer Ingelheim's Micardis Tablets. Mylan received final approval from the US Food and Drug Administration (FDA) for its abbreviated new drug...

Sanofi reports the US Food and Drug Administration (FDA) has accepted for review the company's new drug application (NDA) for Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL),an investigational basal insulin. The acceptance of the...